15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium
Key Takeaways
- The Modified Aldrete Score evaluates 5 physiological domains (Activity, Respiration, Circulation, Consciousness, and Oxygen Saturation), each scored 0 to 2; a cumulative score of ≥9 is mandatory for discharge from Phase I PACU.
- The simplified Apfel PONV risk score consists of 4 independent predictors (Female sex, Non-smoker status, History of PONV or motion sickness, and Postoperative opioid use); risk escalates from ~10% with 0 factors to ~80% with 4 factors.
- Multimodal PONV prophylaxis targets distinct receptor systems: Ondansetron (5-HT3 antagonist, 4 mg at end of surgery), Dexamethasone (corticosteroid, 4-8 mg at induction), Droperidol (D2 antagonist, 0.625-1.25 mg), and Scopolamine (muscarinic antagonist patch preop).
- Negative Pressure Pulmonary Edema (NPPE) is triggered by intense inspiratory effort against an obstructed airway (e.g., post-extubation laryngospasm), generating severe subatmospheric intrathoracic pressure (-50 to -100 cmH2O) that transudates fluid into alveoli; management includes airway clearance, 100% O2, PEEP, and gentle diuresis.
- Emergence delirium is an acute, hyperactive, disoriented state occurring immediately upon waking (common in young children following Sevoflurane and young trauma patients), whereas Postoperative Cognitive Dysfunction (POCD) is a subtle, long-term cognitive deterioration persisting weeks to months postoperatively.
Last updated: August 2026
15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium
The transition of care from the operating room to the Post-Anesthesia Care Unit (PACU) represents a high-vulnerability phase in perioperative medicine. The CRNA must master objective discharge criteria, aggressive multimodal antiemetic strategies, rapid diagnosis of post-extubation respiratory failure, and the clinical distinction between acute emergence delirium and chronic postoperative cognitive decline.
1. PACU Organizational Phases & Fast-Tracking
Post-anesthesia care is divided into functional phases based on patient acuity and level of monitoring required:
+---------------------------------------------------------------------------------------------------------+
| PACU FUNCTIONAL PHASES & DEFINITIONS |
+------------------+----------------------------------+---------------------------------------------------+
| Phase | Primary Clinical Focus | Key Staffing & Monitoring Standards |
+------------------+----------------------------------+---------------------------------------------------+
| **Phase I PACU** | • Acute emergence and recovery | • 1:1 or 1:2 nurse-to-patient ratio |
| | • Re-establishment of airway | • Continuous pulse oximetry, ECG, automated NIBP |
| | reflexes and hemodynamic stab. | • Readiness for transition to Phase II or floor |
+------------------+----------------------------------+---------------------------------------------------+
| **Phase II PACU**| • Step-down recovery preparing | • 1:3 to 1:5 nurse-to-patient ratio |
| | for discharge home / ward | • Focus on oral intake tolerance, ambulation, pain|
| | • Education of patient/caregiver | control, and voiding (when indicated) |
+------------------+----------------------------------+---------------------------------------------------+
| **Fast-Tracking**| • Bypassing Phase I PACU directly| • Utilizes short-acting anesthetics (TIVA, des- |
| | from the OR to Phase II PACU | flurane, remifentanil, regional techniques) |
| | • Reduces hospital costs & stay | • Requires meeting White-Song fast-track criteria |
+------------------+----------------------------------+---------------------------------------------------+
2. Modified Aldrete Scoring System
The Modified Aldrete Score is the gold standard objective metric utilized globally to determine readiness for discharge from Phase I PACU. It evaluates 5 core domains, each graded from 0 to 2 points:
+---------------------------------------------------------------------------------------------------------+
| MODIFIED ALDRETE SCORING CRITERIA |
+-------------------------+---------------------------------------------------------------------+---------+
| Clinical Domain | Evaluation Criteria | Score |
+-------------------------+---------------------------------------------------------------------+---------+
| **1. Motor Activity** | • Moves 4 extremities voluntarily or on command | 2 |
| | • Moves 2 extremities voluntarily or on command | 1 |
| | • Unable to move extremities voluntarily or on command | 0 |
+-------------------------+---------------------------------------------------------------------+---------+
| **2. Respiration** | • Able to breathe deeply and cough freely | 2 |
| | • Dyspneic, shallow, or limited breathing | 1 |
| | • Apneic | 0 |
+-------------------------+---------------------------------------------------------------------+---------+
| **3. Circulation** | • Blood pressure within ± 20% of pre-anesthetic baseline | 2 |
| | • Blood pressure within ± 20% to 50% of pre-anesthetic baseline | 1 |
| | • Blood pressure within ± >50% of pre-anesthetic baseline | 0 |
+-------------------------+---------------------------------------------------------------------+---------+
| **4. Consciousness** | • Fully awake, alert, and oriented | 2 |
| | • Arousable on calling (responds to verbal stimulation) | 1 |
| | • Completely unresponsive | 0 |
+-------------------------+---------------------------------------------------------------------+---------+
| **5. Oxygen Saturation**| • SpO₂ > 92% on room air | 2 |
| | • Requires supplemental O₂ to maintain SpO₂ > 90% | 1 |
| | • SpO₂ < 90% with supplemental oxygen | 0 |
+-------------------------+---------------------------------------------------------------------+---------+
Note on Post-Anesthesia Discharge Scoring System (PADSS) for Ambulatory Discharge: For Phase II discharge to home, the PADSS score evaluates vital signs, ambulation, nausea/vomiting, pain, and surgical bleeding (score $\ge 9/10$ required). Routine mandatory voiding and oral liquid intake are no longer required for all patients prior to discharge unless specifically indicated (e.g., spinal anesthesia, pelvic surgery, history of urinary retention).
3. Postoperative Nausea & Vomiting (PONV): Risk Stratification & Multimodal Prophylaxis
PONV occurs in $30%$ of unselected surgical patients and up to $70 - 80%$ of high-risk patients. It is the leading cause of unexpected hospital admission following ambulatory surgery.
The Simplified Apfel Risk Score
+-------------------------------------------------------------------------+
| APFEL SIMPLIFIED PONV SCORE |
+------------------------------------+------------------------------------+
| The 4 Independent Risk Factors | Risk Factor Count & PONV Incidence |
+------------------------------------+------------------------------------+
| 1. **Female Gender** | • 0 Factors: ~10% risk |
| 2. **Non-Smoker Status** | • 1 Factor: ~20% risk |
| 3. **History of PONV or Motion Sickness** | • 2 Factors: ~40% risk |
| 4. **Postoperative Opioid Use** | • 3 Factors: ~60% risk |
| | • 4 Factors: ~80% (79%) risk |
+------------------------------------+------------------------------------+
[THE EMETIC PATHWAY & RECEPTOR TARGETS]
[Chemoreceptor Trigger Zone (CTZ)] <--- Area Postrema (Outside BBB)
Receptors: 5-HT₃, D₂, NK₁
|
v
[Vomiting Center / NTS (Medulla)] <--- Vestibular System (H₁, M₁)
Receptors: H₁, M₁, NK₁ GI Tract / Vagus (5-HT₃, NK₁)
|
v
[Motor Outflow: Phrenic / Vagal] ---> Diaphragm & Abdominal Wall Contraction
Multimodal Antiemetic Pharmacotherapy
Guidelines recommend administering 2 or more prophylactic antiemetics from different pharmacologic classes for patients with $\ge 2$ Apfel risk factors:
+---------------------------------------------------------------------------------------------------------+
| MULTIMODAL PONV PROPHYLACTIC PHARMACOPEIA |
+---------------------+-------------------+---------------------+-----------------------------------------+
| Drug Class & Name | Standard Dose | Timing of Dose | Mechanism & Clinical Considerations |
+---------------------+-------------------+---------------------+-----------------------------------------+
| **5-HT₃ Antagonist**| 4 mg IV | **At conclusion of**| • Blocks 5-HT₃ receptors in CTZ & vagal |
| *Ondansetron* | | **surgery** | afferents; headache; QT prolongation |
+---------------------+-------------------+---------------------+-----------------------------------------+
| **Corticosteroid** | 4 - 8 mg IV | **At induction of** | • Centrally suppresses prostaglandin/ |
| *Dexamethasone* | | **anesthesia** | endorphin release; delayed onset (~2h)|
| | | | • Transient mild hyperglycemia |
+---------------------+-------------------+---------------------+-----------------------------------------+
| **D₂ Antagonist** | 0.625 - 1.25 mg IV| At conclusion of | • Subcortical D₂ receptor blockade |
| *Droperidol* | | surgery | • FDA black-box warning for QT interval |
| | | | • Extrapyramidal signs (avoid Parkinson)|
+---------------------+-------------------+---------------------+-----------------------------------------+
| **Anticholinergic** | 1.5 mg transdermal| Preoperatively | • Central muscarinic (M₁) receptor antag|
| *Scopolamine Patch* | patch | (or evening prior) | • Anisocoria/cycloplegia if eye contact |
| | | | • Dry mouth, urinary retention, sedation|
+---------------------+-------------------+---------------------+-----------------------------------------+
| **NK₁ Antagonist** | 40 mg PO | 1 - 2 hours preop | • Substance P inhibitor; exceptional for|
| *Aprepitant* | (or Fosaprepitant)| | preventing delayed (24-48h) emesis |
+---------------------+-------------------+---------------------+-----------------------------------------+
| **Propofol TIVA** | Infusion | Maintenance | • Eliminates volatile anesthetics & N₂O |
| | | | • Intrinsic D₂ and 5-HT₃ antagonism |
+---------------------+-------------------+---------------------+-----------------------------------------+
4. PACU Respiratory Emergencies: Hypoxemia & Hypercapnia
Respiratory complications account for the highest proportion of early PACU critical events.
Differential Diagnosis & Management of PACU Hypoxemia
- Atelectasis (Most Common Cause):
- Mechanism: Loss of FRC, compression of lung bases, and absorption atelectasis from high intraoperative $FiO_2$.
- Management: Upright positioning, deep breathing, incentive spirometry, continuous positive airway pressure (CPAP / PEEP).
- Upper Airway Obstruction:
- Mechanism: Pharyngeal soft tissue collapse (tongue falling back against posterior pharynx due to residual sedation/paralysis).
- Management: Jaw thrust, head-tilt/chin-lift, lateral positioning, nasopharyngeal airway (trumpet) or oropharyngeal airway (if unresponsive).
- Post-Extubation Laryngospasm:
- Mechanism: Involuntary reflex spasm of laryngeal adductor muscles (true and false vocal cords) triggered by blood, secretions, or stimulation during light plane of anesthesia (Stage II).
- Management Protocol:
- Step 1: Remove offending stimulus; apply $100% \text{ O}_2$ with tight mask seal.
- Step 2: Apply continuous positive pressure with bag-mask reservoir.
- Step 3: Apply bilateral forceful pressure at Larson's notch (laryngospasm notch behind earlobe between mastoid process and ramus of mandible) with forward jaw thrust.
- Step 4: If refractory, administer Succinylcholine $0.1 - 0.5 \text{ mg/kg}$ IV (subparalytic dose to break spasm while maintaining spontaneous ventilation) or full intubating dose ($1.0 - 1.5 \text{ mg/kg}$ IV or $3 - 4 \text{ mg/kg}$ IM) with atropine if bradycardia occurs.
- Negative Pressure Pulmonary Edema (NPPE / Type I):
- Mechanism: Patient creates forceful, deep inspiratory efforts against a completely obstructed upper airway (e.g., severe laryngospasm, biting ETT). Generates extreme negative intrathoracic pressure ($-50 \text{ to } -100 \text{ cmH}_2\text{O}$), massively increasing venous return, right ventricular preload, and pulmonary capillary hydrostatic pressure, precipitating rapid alveolar transudation.
- Clinical Presentation: Pink, frothy sputum, tachypnea, coarse rales, severe arterial desaturation within minutes.
- Treatment: Relieve obstruction, apply $100% \text{ O}_2$, administer continuous positive airway pressure (CPAP) or re-intubate with PEEP ($5 - 10 \text{ cmH}_2\text{O}$), and provide supportive diuresis.
[NEGATIVE PRESSURE PULMONARY EDEMA PATHWAY]
[Acute Upper Airway Obstruction (Laryngospasm)]
|
v
[Maximal Violent Inspiratory Effort by Patient]
|
v
[Extreme Negative Intrathoracic Pressure: -50 to -100 cmH₂O]
|
v
[Massive Increase in Venous Return & Pulmonary Capillary Hydrostatic P]
|
v
[Alveolar-Capillary Membrane Disruption & Fluid Transudation]
|
v
**[Pink Frothy Secretions, Severe Hypoxemia, Flash Edema]**
Causes of PACU Hypercapnia & Hypoventilation
- Residual Neuromuscular Blockade: Train-of-four (TOF) ratio $<0.9$ causes airway collapse, impaired swallowing, aspiration risk, and hypoventilation. Standard of care requires quantitative neuromuscular monitoring and reversal with Sugammadex or Neostigmine + Glycopyrrolate.
- Opioid-Induced Respiratory Depression: Characterized by slow, deep, regular respirations with pinpoint pupils and hypercapnia. Treat by carefully titrating Naloxone $0.04 - 0.08 \text{ mg}$ IV increments every 2-3 minutes to restore spontaneous ventilation without precipitating acute withdrawal, catecholamine surge, hypertension, and flash pulmonary edema.
5. Emergence Delirium vs Postoperative Cognitive Dysfunction (POCD)
+---------------------------------------------------------------------------------------------------------+
| EMERGENCE DELIRIUM vs POSTOPERATIVE COGNITIVE DYSFUNCTION |
+------------------------+------------------------------------+-------------------------------------------+
| Feature | Emergence Delirium / Agitation | Postoperative Cognitive Dysfunction (POCD)|
+------------------------+------------------------------------+-------------------------------------------+
| **Onset & Timing** | Immediate: upon awakening in PACU | Delayed: manifests weeks to months postop |
| **Duration** | Transient: typically 15 - 45 min | Prolonged: weeks, months, or permanent |
| **Clinical Picture** | Violent motor agitation, thrashing,| Subtle memory loss, executive dysfunction,|
| | crying, combativeness, confusion | personality change, inability to multi-tsk|
| **Risk Populations** | Children (2-6 yr) with Sevoflurane;| Elderly (>65 yr), lower baseline education|
| | young athletic males, PTSD/trauma | major cardiac/orthopedic surgery, ICU stay|
| **Initial Management** | 1. Rule out hypoxemia/hypercapnia | Neuropsychometric baseline testing; multi-|
| | 2. Treat full bladder / pain | multimodal anesthetic depth optimization |
| | 3. Low-dose Dexmedetomidine/Propofol| (avoid excessive burst suppression) |
+------------------------+------------------------------------+-------------------------------------------+
Loading diagram...
Test Your Knowledge
A 28-year-old female non-smoker with a history of severe motion sickness is scheduled for an outpatient laparoscopic cholecystectomy requiring postoperative opioid analgesia. Based on the simplified Apfel score, what is her estimated baseline risk of PONV, and what is the recommended prophylactic approach?
A
B
C
D
Test Your Knowledge
A CRNA evaluates a 45-year-old patient in Phase I PACU following general anesthesia. The patient is awake and responds to verbal commands, is breathing deeply and coughing with a respiratory rate of 16/min, moves all 4 extremities on command, maintains an SpO₂ of 94% on 2 L/min nasal cannula, and has a blood pressure of 135/85 mmHg (baseline 130/80 mmHg). What is the patient's Modified Aldrete Score, and are they eligible for Phase I discharge?
A
B
C
D
Test Your Knowledge
Immediately following extubation after an uneventful umbilical hernia repair, a muscular 24-year-old male develops complete airway obstruction due to severe laryngospasm. Despite breaking the spasm with CPAP and jaw thrust, 5 minutes later the patient develops acute respiratory distress, tachypnea, diffuse bilateral pulmonary rales, and coughs up copious pink, frothy secretions. What is the underlying pathophysiology of this complication?
A
B
C
D
Test Your Knowledge
A 74-year-old patient who underwent an elective total hip arthroplasty under general anesthesia 6 weeks ago is brought to the clinic by family members who report that the patient has experienced new-onset subtle memory deficits, difficulty balancing a checkbook, and impaired multitasking, despite being alert, oriented, and without focal neurologic deficits. How is this condition best characterized compared to emergence delirium?
A
B
C
D